https://scholars.lib.ntu.edu.tw/handle/123456789/202763
標題: | Effects of Propofol on Functional Activities of Hepatic and Extrahepatic Conjugation Enzyme Systems | 作者: | Chen, T. L. Wu, C. H. Chen, T. G. Tai, Y. T. Chang, H. C. Lin, C. J. |
關鍵字: | anaesthetics i.v.;propofol;enzymes;liver;microsomes | 公開日期: | 2000 | 卷: | v.84 | 期: | n.6 | 起(迄)頁: | 771-776 | 來源出版物: | BRITISH JOURNAL OF ANAESTHESIA | 摘要: | The effect of propofol on the hepatic and extrahepatic conjugation enzyme systems was assessed in vitro using microsomal and cytosolic preparations of human liver, hamster kidney, lung and gut. The functional activities of phase-II enzymes, including uridine diphosphate- glucuronosyltransferase (UDPGT), glutathione S-transferase ( GST) and N- acetyltransferase (NAT) were evaluated in the presence of various concentrations of propofol (0.05-1.0 mmol litre(-1)), using 1-naphthol, 1- chloro-2,4- dinitrobenzene and p-aminobenzoic acid as substrates respectively. Propofol produced concentration-dependent inhibition of UDPGT activity in human liver microsomes. Propofol did not produce significant inhibition of human hepatic GST activity at concentrations below 1.0 mmol litre( -1). In contrast, NAT activity was unaffected by propofol 0. 05-1.0 mmol litre(-1) in human liver cytosolic preparations . in extrahepatic tissues, hamster renal and intestinal UDPGT activities were significantly inhibited by propofol at 0.25-1.0 mmol litre(-1). In these tissues, GST and NAT were unaffected by propofol at 1.0 mmol litre(- 1). Propofol produced differential inhibition of human liver and hamster extrahepatic conjugation enzymes as a result of different substrate and tissue specificities. The potential interference of the metabolic profile of phase-II enzymes as a result of inhibition by propofol (especially of UDPGT and GST) should be considered when using propofol with other drugs for anaesthesia. |
URI: | http://ntur.lib.ntu.edu.tw//handle/246246/99197 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。